// App-Quantinova.ai

PB1106 : Combined Gene and Cell Therapy for the Treatment of Hemophilia A within an Implantable Therapeutic Device

Researchers

Presenter

  • C. Olgasi

Principal Investigators

  • S. Merlin

  • C. Borsotti

  • A. Cucci

  • T. Bergmann

  • P. Bittorf

  • K. Patterson

  • D.M. Mazzuca

  • A. Stolzing

  • M. Zierau

  • P.M. Toleikis

  • F. Benedicenti

  • A. Calabria

  • E. Montini

  • J. Braspenning

  • A. Follenzi

Medical Centers

  • University of Piemonte Orientale, Department of Translational Medicine, Novara, Italy

  • University Hospital Würzburg, Department of Tissue Engineering and Regenerative Medicine, Würzburg, Germany

  • Sernova Corp, London, Canada

  • Loughborough University, Centre for Biological Engineering, School of Mechanical, Electrical and Manufacturing Engineering, Loughborough, United Kingdom

  • IMS Integrierte Management Systeme e. K., Heppenheim, Germany

  • San Raffaele Telethon Institute for Gene Therapy, SR-Tiget, TIGET Vector Integration Core, Milano, Italy

Locations

  • Italy

  • Germany

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved